Published in Stroke on November 01, 1997
Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J Physiol (2004) 2.42
Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A (2000) 1.90
The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J Neuroinflammation (2010) 1.54
Leukocyte recruitment and ischemic brain injury. Neuromolecular Med (2009) 1.47
Role of P-selectin cytoplasmic domain in granular targeting in vivo and in early inflammatory responses. J Cell Biol (1998) 1.43
Endothelial activation and circulating markers of endothelial activation in kidney disease. Nat Rev Nephrol (2010) 1.16
Systemic complement activation following human acute ischaemic stroke. Clin Exp Immunol (2004) 1.16
Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair. Prog Neurobiol (2013) 1.09
Clinical trials for cytoprotection in stroke. NeuroRx (2004) 1.08
Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis. Blood (2009) 1.05
Inflammation after stroke: mechanisms and therapeutic approaches. Transl Stroke Res (2010) 1.01
Human cellular inflammation in the pathology of acute cerebral ischaemia. J Neurol Neurosurg Psychiatry (2003) 0.97
Serum concentration of adhesion molecules in patients with delayed ischaemic neurological deficit after aneurysmal subarachnoid haemorrhage: the immunoglobulin and selectin superfamilies. J Neurol Neurosurg Psychiatry (2001) 0.89
Circulating soluble E-selectin in early rheumatoid arthritis: a prospective five year study. Ann Rheum Dis (2002) 0.84
Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus. Clin Exp Immunol (2001) 0.83
Novel Biomarkers Associated with Deep Venous Thrombosis: A Comprehensive Review. Biomark Insights (2008) 0.83
E-selectin and vascular cell adhesion molecule-1 as biomarkers of 3-month outcome in cerebrovascular diseases. J Inflamm (Lond) (2015) 0.81
Role of cell adhesion molecules in acute ischemic stroke. Ann Saudi Med (2011) 0.81
Endothelial cell activation markers and delayed cerebral ischaemia in patients with subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (2006) 0.80
Endothelial dysfunction and procoagulant activity in acute ischemic stroke. J Vasc Interv Neurol (2012) 0.80
Targeting specific cells in the brain with nanomedicines for CNS therapies. J Control Release (2015) 0.79
Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia. Stem Cell Res Ther (2016) 0.77
Both MC1 and MC3 Receptors Provide Protection From Cerebral Ischemia-Reperfusion-Induced Neutrophil Recruitment. Arterioscler Thromb Vasc Biol (2015) 0.76
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
Interobserver agreement for the assessment of handicap in stroke patients. Stroke (1988) 20.14
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet (2006) 10.72
Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol (2000) 5.34
[TIA... an aspirin?]. Ned Tijdschr Geneeskd (1995) 5.21
Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry (2001) 4.51
Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke (1997) 4.13
Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke (1998) 4.12
Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75
Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke (1996) 3.67
Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet (2005) 3.46
[Fever, large eyes and confusion; the anticholinergic syndrome]. Ned Tijdschr Geneeskd (2002) 3.30
Images in clinical medicine. Heparin-induced skin necrosis. N Engl J Med (1996) 3.30
Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature (1979) 3.06
[Those who cannot remember the past are condemned to repeat it]. Ned Tijdschr Geneeskd (2006) 2.98
Intracerebral hematomas during anticoagulant treatment. Stroke (1990) 2.97
CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem (1991) 2.82
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke (2005) 2.69
Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke (1998) 2.40
Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology (1998) 2.39
Lack of discriminating signs and symptoms in clinical diagnosis of influenza of patients admitted to the hospital. Infection (2007) 2.35
Spinal dural arteriovenous fistulas: a congestive myelopathy that initially mimics a peripheral nerve disorder. Brain (2006) 2.35
Hypertension and cerebral white matter lesions in a prospective cohort study. Brain (2002) 2.31
Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature (1986) 2.31
Outcome in patients with subarachnoid haemorrhage and negative angiography according to pattern of haemorrhage on computed tomography. Lancet (1991) 2.30
Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease. Nat New Biol (1972) 2.30
The diagnosis of subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1990) 2.29
Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage. Neurology (1985) 2.18
Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry (1990) 2.15
Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke (1994) 2.14
Thunderclap headache as first symptom of cerebral venous sinus thrombosis. CVST Study Group. Lancet (1996) 2.14
Carotid endarterectomy with transcranial Doppler and electroencephalographic monitoring. A prospective study in 130 operations. Stroke (1993) 2.13
Extremely high levels of von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment. J Thromb Haemost (2003) 2.12
Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. Blood (2000) 2.12
Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2007) 2.08
The time course of aneurysmal haemorrhage on computed tomograms. Neuroradiology (1982) 2.06
Ticlopidine, trials, and torture. Stroke (1994) 2.04
[Effectiveness of endarterectomy for symptomatic stenosis of the internal carotid artery; more risk factors important than only the severity of the stenosis]. Ned Tijdschr Geneeskd (2007) 2.04
[There is no such thing as the CVA]. Ned Tijdschr Geneeskd (1991) 2.03
[Functional imaging of the brain in the investigation of chronic unexplained pain]. Ned Tijdschr Geneeskd (2007) 2.02
Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol (1990) 2.00
Xanthochromia after subarachnoid haemorrhage needs no revisitation. J Neurol Neurosurg Psychiatry (1989) 1.95
[Thrombolytic therapy of brain infarct: the end of beginning]. Ned Tijdschr Geneeskd (2000) 1.94
Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial. Ann Intern Med (1995) 1.93
Symptomatic carotid artery occlusion. A reappraisal of hemodynamic factors. Stroke (1997) 1.92
[Possible treatments for patients with symptomatic carotid artery stenosis]. Ned Tijdschr Geneeskd (2005) 1.92
The clinical course of perimesencephalic nonaneurysmal subarachnoid hemorrhage. Ann Neurol (1991) 1.89
Warning headache in aneurysmal subarachnoid hemorrhage. A case-control study. Arch Neurol (1988) 1.89
Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. Blood (1998) 1.88
Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg (1985) 1.87
Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry (1996) 1.87
Ischemic stroke in young adults. Experience in 329 patients enrolled in the Iowa Registry of stroke in young adults. Arch Neurol (1995) 1.83
Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke (1990) 1.83
Recurrent ischemia in symptomatic carotid occlusion: prognostic value of hemodynamic factors. Neurology (2000) 1.80
Graft-versus-myeloma effect in two cases. Lancet (1996) 1.80
Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? Am J Gastroenterol (2000) 1.78
A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia (2009) 1.76
The Corsi Block-Tapping Task: standardization and normative data. Appl Neuropsychol (2000) 1.74
Long-term follow-up of 71 patients with thunderclap headache mimicking subarachnoid haemorrhage. Lancet (1988) 1.73
Changes in functional outcome and quality of life in patients and caregivers after aneurysmal subarachnoid hemorrhage. J Neurosurg (2001) 1.73
Spinal infarction. A follow-up study. Stroke (1993) 1.72
[On the way to our 200th anniversary]. Ned Tijdschr Geneeskd (2007) 1.72
Apnoea testing to confirm brain death in clinical practice. J Neurol Neurosurg Psychiatry (1986) 1.72
[Diagnostic image (156). A man with a hematoma behind the ear. Mastoid bone fracture]. Ned Tijdschr Geneeskd (2003) 1.69
[Creative mathematics with clopidogrel; exaggeration of the preventive effect by manufacturer]. Ned Tijdschr Geneeskd (1999) 1.68
Risk of cardiac events in atypical transient ischaemic attack or minor stroke. The Dutch TIA Study Group. Lancet (1992) 1.68
Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura. J Thromb Haemost (2006) 1.68
A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol (1999) 1.67
Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators. Neurology (1993) 1.63
von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura. Blood (1999) 1.62
Subarachnoid haemorrhage in first and second degree relatives of patients with subarachnoid haemorrhage. BMJ (1995) 1.62
Detection of subarachnoid haemorrhage on early CT: is lumbar puncture still needed after a negative scan? J Neurol Neurosurg Psychiatry (1995) 1.61
Occurrence of hemispheric and retinal ischemia in atrial fibrillation compared with carotid stenosis. Stroke (2002) 1.61
Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke (2002) 1.60
Role of collateral flow on cerebral hemodynamics in patients with unilateral internal carotid artery occlusion. Ann Neurol (1998) 1.60
Structure-function relationship of human von Willebrand factor. Blood (1987) 1.60
Outcome in familial subarachnoid hemorrhage. Stroke (1995) 1.59
Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans (2005) 1.59
Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia (2007) 1.59
Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood. Arteriosclerosis (1989) 1.57
Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation (1999) 1.54
Increased thromboxane biosynthesis in patients with acute cerebral ischemia. Stroke (1993) 1.54
Prediction of cerebral hyperperfusion after carotid endarterectomy with transcranial Doppler. Eur J Vasc Endovasc Surg (2012) 1.53
[Missing spleen: indication for pneumococcal vaccination]. Ned Tijdschr Geneeskd (2003) 1.53
Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke (1988) 1.52